Cedar Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-6,030
| Closed | -$528K | – | 49 |
|
|
2020
Q3 | $528K | Buy |
+6,030
| New | +$528K | 0.17% | 124 |
|
|
2020
Q1 | – | Sell |
-4,515
| Closed | -$400K | – | 150 |
|
|
2019
Q4 | $400K | Buy |
+4,515
| New | +$400K | 0.18% | 132 |
|
|
2019
Q3 | – | Sell |
-3,551
| Closed | -$258K | – | 163 |
|
|
2019
Q2 | $258K | Buy |
3,551
+495
| +16% | +$36K | 0.11% | 149 |
|
|
2019
Q1 | $246K | Sell |
3,056
-129
| -4% | -$10.4K | 0.11% | 148 |
|
|
2018
Q4 | $294K | Buy |
3,185
+184
| +6% | +$17K | 0.15% | 129 |
|
|
2018
Q3 | $284K | Buy |
3,001
+274
| +10% | +$25.9K | 0.11% | 148 |
|
|
2018
Q2 | $253K | Buy |
2,727
+338
| +14% | +$31.4K | 0.11% | 138 |
|
|
2018
Q1 | $226K | Buy |
2,389
+189
| +9% | +$17.9K | 0.11% | 140 |
|
|
2017
Q4 | $213K | Buy |
+2,200
| New | +$213K | 0.1% | 125 |
|